Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2008
11/20/2008US20080287448 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/20/2008US20080287447 Methods for preparing eszopiclone
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287434 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/20/2008US20080287430 Furan Compounds Useful As Ep1 Receptor Antagonists
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
11/20/2008US20080286810 Use of Inhibtors of Glutaminyl Cyclases for Treatment and Prevention of Disease
11/20/2008CA2686926A1 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
11/20/2008CA2686489A1 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/20/2008CA2686385A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
11/20/2008CA2685888A1 Substituted heterocyclic derivatives and their pharmaceutical use and compositions
11/20/2008CA2685757A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/19/2008EP1992626A1 Process for the preparation of moxifloxacin hydrochloride
11/19/2008EP1992621A1 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases
11/19/2008EP1991546A1 NOVEL DIBENZO[c,h][1,5]NAPHTHYRIDINES AND THEIR USE AS DNA PROBES
11/19/2008EP1991545A2 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
11/19/2008EP1991531A1 Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors
11/19/2008EP1991227A2 Prolyl hydroxylase inhibitors
11/19/2008EP1853606B1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs
11/19/2008EP1537108B1 Di and trifluoro-triazolo-pyridines anti-inflammatory compounds
11/19/2008EP1485382B1 Process for the synthesis of pergolide
11/19/2008EP1417349B1 Novel molecular target for neurotoxicity
11/19/2008CN101309922A Amino-aza-adamantane derivatives and methods of use
11/19/2008CN101309921A Use of pyrrolo[2,3-B]pyridines to prepare a medicament for treating pain
11/19/2008CN101309904A 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
11/19/2008CN101308906A Electron transporting materials and organic light-emitting devices therewith
11/19/2008CN100434429C Method for preparing 2-arylimidazo [2,1-alpha] isoquinoline
11/19/2008CN100434420C Compound inhibiting dipeptidyl peptidase iv
11/18/2008US7452998 preparing an optically pure proton pump inhibitor having a sulfinyl structure using a chiral zirconium complex or a chiral hafnium complex; comprising oxidizing a corresponding sulfide
11/18/2008US7452993 morpholin-4-yl-{3-[3-(1H-pyrazol-4-yl)-1H-pyrazolo[3,4-b]pyridin-5-yl-phenyl}-methanone; FMS-like tyrosine kinase 3 (FLT3), is implicated in cancers, including leukemia, such as acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplasia
11/18/2008US7452992 Heterocyclic compounds as CCR5 antagonists
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452908 Amide derivatives
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452903 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
11/18/2008US7452902 Imidazopyridines as cyclin dependent kinase inhibitors
11/18/2008US7452897 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases
11/18/2008US7452890 Substituted pyrazoles
11/18/2008US7452883 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
11/18/2008US7452881 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide; serotonin receptors antagonist; anxiolytic, antidepressant, cognitive activator, senile dementia, psychosis, attention deficit/hyperactivity disorder
11/18/2008US7452880 p38 kinase inhibitors; arthritis, Crohn's disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease; pyrazolo(3,4-d)pyrimidines
11/18/2008US7452385 Naphthalene derivatives and colorants for keratin fibers containing these compounds
11/18/2008CA2440222C Triazolopyridines as anti-inflammatory agents
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2383630C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
11/18/2008CA2358487C Use of phanquinone for the treatment or prevention of memory impairment
11/18/2008CA2301646C Pharmaceutical suspension comprising nevirapine hemihydrate
11/13/2008WO2008137474A1 Morphinan compounds
11/13/2008WO2008137436A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
11/13/2008WO2008137435A1 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
11/13/2008WO2008137176A1 Pyrazolo-pyridinone compounds, process for their preparation, and their pharmaceutical use
11/13/2008WO2008137084A2 Diazaquinolones that inhibit prolyl hydroxylase activity
11/13/2008WO2008137027A2 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation
11/13/2008WO2008136948A1 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
11/13/2008WO2008136444A1 Fused heterocyclic derivative
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008WO2008136378A1 Novel sulfonamide derivative and salt thereof
11/13/2008WO2008135791A1 Imidazoquinolines with immuno-modulating properties
11/13/2008WO2008135785A1 9- (pyrazol- 3 -yl) - 9h- purine-2 -amine and 3- (pyraz0l-3-yl) -3h-imidaz0 [4, 5-b] pyridin-5-amine derivatives and their use for the treatment of cancer
11/13/2008WO2008135442A1 Heterocyclic compounds and their use as pesticides
11/13/2008WO2008118718A3 2-aminopyridine analogs as glucokinase activators
11/13/2008WO2008118454A3 Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
11/13/2008WO2008115098A3 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof
11/13/2008WO2008103470A3 Oncogenic-ras-signal dependent lethal compounds
11/13/2008WO2008100620A3 Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
11/13/2008WO2008099186A8 Heterocyclic derivatives as m3 muscarinic receptors
11/13/2008WO2008099072A3 New 2, 4-dianilinopyrimidines, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
11/13/2008WO2008078100A3 Tricyclic amine derivatives as protein tyrosine kinase inhibitors
11/13/2008WO2008064265A3 Compounds modulating c-fms and/or c-kit activity and uses therefor
11/13/2008WO2008028168A3 Serine-threonine protein kinase and parp modulators
11/13/2008WO2008024433A3 Haloalkyl-substituted pyrimidinone derivatives
11/13/2008WO2008005908A3 Pyridoimidazole derivatives
11/13/2008US20080280946 Azaindole-Derivatives As Factor Xa Inhibitors
11/13/2008US20080280945 Crystalline forms of an HIV integrase inhibitor
11/13/2008US20080280942 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands
11/13/2008US20080280941 8-Phenoxy-Gamma Carboline Derivatives
11/13/2008US20080280934 Porphyrin ring compound containing cyanovinyl group; reacted with Vilsmeier reagent,complexed with metal ion in prsence of an acid and oxidizer; skin disorders; antiinflammatory agents; anticancer agents; antitumor agents; vascular disorders, vision defects, urogenital system disorders; immunology
11/13/2008US20080280928 Pyrrolopyrimidine and Pyrrolopyridine Derivatives Substituted with a Cyclic Amino Group As Crf Antagonists
11/13/2008US20080280917 Nitrogen-Containing heterocyclyl ketones and methods of use
11/13/2008US20080280913 dipeptidyl-peptidase IV (DPP-IV) inhibitors such as 5,5,6,6,8,8-d6-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine; increasing hormone glucagon-like peptide levels; pharmacokinetics; side effect reduction
11/13/2008US20080280912 Diagnosis test; mixing blood or other fluid sample with test compound; analyzing, calibration; central nervous system disorders; analgesics; antiinflamamtory agents; drug abuse; anxiolytic agents; cognition activators;Alzheimer's disease; Parkinson's disease; Huntington's disease; hyperactivity
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280899 Cancer; such as 3-({4-[2-(methylthio)-6-phenylpyrido[2,3-d]pyrimidin-7-yl]benzyl}amino)-1-phenylpropan-1-one; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity
11/13/2008US20080280895 5-Amino-4-Hydroxy-7-(1H-Indolmethyl)-8-Methylnonamide Derivatives as Renin Inhibitors for the Treatment of Hypertension
11/13/2008US20080280892 Tricyclic nitrogen antibacterial; 1-({4-[(2,3-Dihydro[1,4]dioxino[2,3-c]pyridin-7-ylmethyl)amino]-1-piperidinyl}methyl)-9-fluoro-1,2-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one; may be used with other active ingredients, diluents
11/13/2008US20080280871 5-Phenyl-4-Methyl-Thiazol-2-Yl-Amine Derivatives as Inhibitors of Phosphatidylin Ositol 3 Kinase Enzymes (PI13) For Treatment of Inflammatory Diseases
11/13/2008US20080280857 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
11/13/2008US20080280766 Pyridopyrazines for Combating Phytopathogenic Fungi
11/13/2008US20080277622 Oxygen Scavenging Molecules, Articles Containing Same, And Methods Of Their Use
11/13/2008CA2686163A1 Imidazoquinolines with immuno-modulating properties
11/13/2008CA2685723A1 Morphinan compounds
11/13/2008CA2685215A1 Compounds and methods useful for treating asthma and allergic inflammation
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008CA2684693A1 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatmentof cancer
11/13/2008CA2683821A1 Heterocyclic compounds and their use as pesticides
11/13/2008CA2674831A1 5,6-ring annulated indole derivatives and methods of use thereof
11/12/2008EP1990343A2 Azaindoles
11/12/2008EP1990342A1 Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof
11/12/2008EP1990335A1 17 beta hsd type 5 inhibitor
11/12/2008EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation
1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 646